A review of new hormonal therapies for prostate cancer in black men: is there enough data?

by Matthias E. Meunier, Pascal Blanchet, Yann Neuzillet, Thierry Lebret, Laurent Brureau
Published 2021-01-01

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer

by Yann Neuzillet, Elodie Chapeaublanc, Clémentine Krucker, Leanne De Koning, Thierry Lebret, François Radvanyi, Isabelle Bernard-Pierrot
Published 2017-09-01

Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.

by Marie Simon, Pierre-Olivier Bosset, Mathieu Rouanne, Simone Benhamou, Camelia Radulescu, Vincent Molinié, Yann Neuzillet, Xavier Paoletti, Thierry Lebret
Published 2019-01-01

Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy

by Thierry Lebret, Alain Ruffion, Igor Latorzeff, Marc Zerbib, Jean-Luc Moreau, Dominique Rossi, Nathalie Pello-Leprince-Ringuet, Valérie Perrot, Christophe Hennequin
Published 2018-12-01

Deregulation of Rab and Rab effector genes in bladder cancer.

by Joel R Ho, Elodie Chapeaublanc, Lisa Kirkwood, Remy Nicolle, Simone Benhamou, Thierry Lebret, Yves Allory, Jennifer Southgate, François Radvanyi, Bruno Goud
Published 2012-01-01

Effects of Adenosine Monophosphate Used in Combination with L‐Arginine on Female Rabbit Corpus Cavernosum Tissue

by Olivier Stücker, PhD, Catherine Pons, PhD, Yann Neuzillet, MD, PhD, Elisabeth Laemmel, PhD, Thierry Lebret, MD, PhD
Published 2014-04-01

Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study

by Thierry Lebret, Jean-Louis Davin, Christophe Hennequin, Igor Latorzeff, Jean-Pierre Mignard, Jean-Luc Moreau, Dominique Rossi, Alain Ruffion, Marc Zerbib, Stéphane Culine
Published 2014-12-01

Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy

by Yann Neuzillet, Mathieu Rouanne, Jean-François Dreyfus, Jean-Pierre Raynaud, Marc Schneider, Morgan Roupret, Sarah Drouin, Marc Galiano, Xavier Cathelinau, Thierry Lebret, Henry Botto
Published 2021-01-01

Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy

by Yann Neuzillet, Jean-François Dreyfus, Jean-Pierre Raynaud, Mathieu Rouanne, Marc Schneider, Morgan Roupret, Sarah Drouin, Marc Galiano, Xavier Cathelineau, Thierry Lebret, Henry Botto
Published 2021-01-01

Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer

by Mathieu Rouanne, François Gaillard, Matthias E. Meunier, Yanish Soorojebally, Hoang Phan, Hind Slimani-Thevenet, Anne-Sophie Jannot, Yann Neuzillet, Gérard Friedlander, Marc Froissart, Henry Botto, Pascal Houillier, Thierry Lebret, Marie Courbebaisse
Published 2020-09-01

Author Correction: Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer

by Mathieu Rouanne, François Gaillard, Matthias E. Meunier, Yanish Soorojebally, Hoang Phan, Hind Slimani-Thevenet, Anne-Sophie Jannot, Yann Neuzillet, Gérard Friedlander, Marc Froissart, Henry Botto, Pascal Houillier, Thierry Lebret, Marie Courbeba
Published 2021-03-01

Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes

by Anne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, Clémentine Krucker, Elodie Chapeaublanc, Carlota Rubio-Pérez, Nuria López-Bigas, Aurélie Kamoun, Yann Neuzillet, Pierre Gestraud, Luca Grieco, Sandra Rebouissou, Aurélien de Reyniès, Simone Benhamou, Thierry Lebret, Jennifer Southgate, Emmanuel Barillot, Yves Allory, Andrei Zinovyev, François Radvanyi
Published 2014-11-01

A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.

by Yann Neuzillet, Xavier Paoletti, Slah Ouerhani, Pierre Mongiat-Artus, Hany Soliman, Hugues de The, Mathilde Sibony, Yves Denoux, Vincent Molinie, Aurélie Herault, May-Linda Lepage, Pascale Maille, Audrey Renou, Dimitri Vordos, Claude-Clément Abbou, Ashraf Bakkar, Bernard Asselain, Nadia Kourda, Amel El Gaaied, Karen Leroy, Agnès Laplanche, Simone Benhamou, Thierry Lebret, Yves Allory, François Radvanyi
Published 2012-01-01